For women undergoing fertility treatments, the use of selective serotonin reuptake inhibitors use may decrease pregnancy rates and increase miscarriage rates.
Use of surgical mesh to correct vaginal vault prolapse after a hysterectomy is associated with a lower risk of prolapse recurrence at 1 year than sacrospinous fixation (SSF), according to results of a new study
The available evidence that selective estrogen receptor modulators (SERMs) can reduce the size of fibroids or improve clinical symptoms is inconsistent, according to the results of an updated intervention review conducted by the Cochrane Menstrual Disorders and Subfertility Group.
Topical or intracervical 2% lidocaine gel applied before intrauterine device (IUD) insertion does not decrease pain scores, but there are other ways to lessen discomfort.
An updated intervention review of the use of methenamine hippurate for the prevention of urinary tract infections has found that methenamine may effectively prevent UTIs in certain patient populations.
Women with primary breast cancer diagnosed at an advanced stage are at increased risk for the development of contralateral breast cancer (CBC), according to the results of a population-based study conducted in Sweden.
An intrauterine device (IUD) is an effective tool in the treatment of early-stage endometrial cancer in certain patients, according to the results of a small study presented at the International Gynecological Cancer Society’s 14th biennial meeting.
Compared with older low-dose combined hormonal contraceptives (CHCs), drospirenone-containing contraceptives are associated with a higher risk of thrombotic events, according to the results of a new FDA-funded study.
Neoadjuvant chemotherapy is a reasonable alternative to primary debulking surgery in women with stage IIIc/IV ovarian cancer, according to new intervention review.
In a new study, women who initiated hormone replacement therapy soon after beginning menopause and who continued treatment for 10 years had significantly reduced risk of myocardial infarction, heart failure, or death with no increased risk of cancer, venous thromboembolism, or stroke.